NCT07437846 Impact of PEEP on Respiratory Effort During Assisted Ventilation
| NCT ID | NCT07437846 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pontificia Universidad Catolica de Chile |
| Condition | Mechanical Ventilation |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2025-01-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assisted mechanical ventilation is widely used to preserve diaphragmatic activity and improve lung aeration in patients with acute respiratory failure. However, during assisted ventilation, excessive inspiratory effort may develop and contribute to lung injury, diaphragmatic overload, and patient self-inflicted lung injury. Optimizing ventilator settings to modulate respiratory effort therefore represents a major physiological and clinical challenge. Positive end-expiratory pressure (PEEP) is a key determinant of lung recruitment and respiratory system mechanics and may influence inspiratory effort by modifying lung volume, compliance, and respiratory drive. Despite its widespread use, PEEP titration in clinical practice is still mainly guided by oxygenation parameters, while its direct effects on inspiratory effort during assisted mechanical ventilation remain insufficiently characterized. This physiological randomized crossover study aims to evaluate the effect of four predefined levels of positive end-expiratory pressure (0, 5, 10, and 15 cmH₂O) on the respiratory system and inspiratory effort in adult patients receiving assisted mechanical ventilation. Patients will be exposed to each PEEP level in randomized order, with stabilization and washout periods between conditions, while ventilatory support settings other than PEEP are kept constant.
Eligibility Criteria
Inclusion criteria: * Age ≥18 years. * ICU patients receiving invasive mechanical ventilation (endotracheal tube or tracheostomy). * Ventilated in an assisted mode with spontaneous breathing * Clinically stable to undergo protocolized PEEP changes. * Sedation level compatible with spontaneous breathing and ventilator triggering * Informed consent from the patient or legally authorized representative. Exclusion Criteria: * Contraindication to esophageal balloon placement (if applicable). * Significant hemodynamic instability or unstable vasopressor requirements. * Unstable arrhythmia or active myocardial ischemia. * Undrained pneumothorax or major air leak. * Controlled ventilation without effective spontaneous effort (apnea, neuromuscular blockade, deep sedation). * Pregnancy * Acute or chronic neurological conditions that may impair respiratory drive or interfere with the regulation of spontaneous breathing.
Contact & Investigator
Roque Basoalto, PhD, Msc, Physioterapy
PRINCIPAL INVESTIGATOR
Pontifica Universidad Catolica de Chile
Frequently Asked Questions
Who can join the NCT07437846 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07437846 currently recruiting?
Yes, NCT07437846 is actively recruiting participants. Contact the research team at diegon.lopez@uc.cl for enrollment information.
Where is the NCT07437846 trial being conducted?
This trial is being conducted at Santiago, Chile.
Who is sponsoring the NCT07437846 clinical trial?
NCT07437846 is sponsored by Pontificia Universidad Catolica de Chile. The principal investigator is Roque Basoalto, PhD, Msc, Physioterapy at Pontifica Universidad Catolica de Chile. The trial plans to enroll 12 participants.